Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: A retrospective analysis of pooled, prospective phase 2 trials

Guru Sonpavde, Gregory R. Pond, Ronan Fougeray, Toni K. Choueiri, Angela Q. Qu, David J. Vaughn, Guenter Niegisch, Peter Albers, Nicholas D. James, Yu Ning Wong, Yoo Joung Ko, Srikala S. Sridhar, Matthew D. Galsky, Daniel P. Petrylak, Ulka N. Vaishampayan, Awais Khan, Nicholas J. Vogelzang, Tomasz M. Beer, Walter M. Stadler, Peter H. O'DonnellCora N. Sternberg, Jonathan E. Rosenberg, Joaquim Bellmunt

Research output: Contribution to journal › Article › peer-review

104 Scopus citations

Fingerprint

Dive into the research topics of 'Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: A retrospective analysis of pooled, prospective phase 2 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences